相关实验视频
Updated: Jul 13, 2025

10:42
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
9.4K
含有Pt (II) 复合体的核基与红细胞的兼容性,用于可能的药物输送应用
Federica De Castro1, Erika Stefàno1, Francesco Paolo Fanizzi1
1Department of Biological and Environmental Sciences and Technologies, University of Salento, Via Monteroni, 73100 Lecce, Italy.
Molecules (Basel, Switzerland)
|October 14, 2023
概括
研究人员探索了将 (Pt) 复合物加载到红细胞 (RBC) 中,用于药物输送. 这些Pt(II) 复合物表现出稳定性,为向抗癌和抗病毒疗法开辟了新的途径.
科学领域:
- 药用化学 医学化学
- 纳米技术 纳米技术
- 生物化学 生化学
背景情况:
- 复合物和核类类似物是已确定的抗癌和抗病毒药物.
- 红血细胞 (RBC) 提供了一个生物相容的平台,用于向药物输送,保护药剂免受无活化并改善生物分布.
研究的目的:
- 评估将含有核基的特定 (II) 复合物加载到人体红细胞中的可行性.
- 评估这些充满RBC的稳定性和潜力,以便在未来的抗瘤和抗病毒应用中使用.
主要方法:
- (II) 复合物的合成和特征与瓜诺辛,2'-脱氧-瓜诺辛和5'-(2'-脱氧) - 瓜诺辛三酸盐.
- 研究这些复合物的稳定性和融入人体红细胞.
主要成果:
- 研究的 (II) 复合物,[PtII (((dien) ((N7-Guo) ]2+,[PtII (((dien) ((N7-dGuo) ]2+,和[PtII (((dien) ((N7-dGTP) ],被发现是稳定的.
- 这些复杂物被成功地纳入人体红细胞,证明它们适合这种药物输送系统.
结论:
- 人类红细胞可以被用作基于的核酸相似物的一种可行的载体.
- 这种方法有望开发新的针对性治疗方法来治疗癌症和病毒感染,使用金属核基相似物.
更多相关视频
相关概念视频
Pore Transport and Ion-Pair Transport
483
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
483
Phase II Reactions: Miscellaneous Conjugation Reactions
64
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
64
Drug Binding to Blood Components
155
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
155
Drug Distribution: Tissue Binding
2.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.7K
Tissue-Drug Binding: Localization of Drugs and its Significance
87
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
87
Drug Metabolism: Phase II Reactions
3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K

